Stacks Image 2648

TODD BIXBY

BIOTECHNOLOGY
& THE PUBLIC GOOD
STRATEGIST. ANALYST. DEVELOPER. INNOVATOR.
Advancing biotechnologies for human health, environmental health, biodefense and national security for over 20 years.
Currently focused on building and advising technology startups and new ventures.
EXPERIENCE HIGHLIGHTS - click to read more
HIGHLIGHTS
  • Part of technical team that transitioned testing of US blood supply from immunoassay to more sensitive molecular tests for the safety of nation's blood supply and launched the APTIMA infectious disease molecular diagnostic platforms (NASDAQ:GPRO)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, tuberculosis, malaria, malnutrition, sanitation, clean water, healthy air, agriculture, and health education to reduce burden of chronic and infectious diseases
  • Served as strategist and technology analyst across sectors for publicly-traded biotechnology company (NASDAQ:XON) and FORBES 400 largest individual American biotech investor

read more…
Stacks Image 2650

TODD BIXBY

BIOTECHNOLOGY & THE PUBLIC GOOD
STRATEGIST. ANALYST. DEVELOPER. INNOVATOR.
Advancing biotechnologies for human health, environmental health, biodefense and national security for over 20 years.
Currently focused on building and advising technology startups and new ventures.
EXPERIENCE HIGHLIGHTS - click to read more
HIGHLIGHTS
  • Part of technical team that transitioned testing of US blood supply from immunoassay to more sensitive molecular tests for the safety of nation's blood supply and launched the APTIMA infectious disease molecular diagnostic platforms (NASDAQ:GPRO)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, tuberculosis, malaria, malnutrition, sanitation, clean water, healthy air, agriculture, and health education to reduce burden of chronic and infectious diseases
  • Served as strategist and technology analyst across sectors for publicly-traded biotechnology company (NASDAQ:XON) and FORBES 400 largest individual American biotech investor

read more…
  • Part of technical team that transitioned testing of US blood supply from immunoassay to more sensitive molecular tests for the safety of nation's blood supply and launched the APTIMA infectious disease molecular diagnostic platforms (NASDAQ:GPRO)
  • Performed global health fieldwork and international development in Sub-Saharan Africa with interventions targeting HIV, tuberculosis, malaria, malnutrition, sanitation, clean water, healthy air, agriculture, and health education to reduce burden of chronic and infectious diseases
  • Served as strategist and technology analyst across sectors for publicly-traded biotechnology company (NASDAQ:XON) and FORBES 400 largest individual American biotech investor

read more…
INTRODUCING OUR TECHNOLOGY DEVELOPMENT ENGINE
FOR HEALTHIER PEOPLE AND A HEALTHIER PLANET
VENTURE STUDIO
Stacks Image 2574
PUBLIC GOOD VENTURES LLC
Venture studio and management advising company focused on fundraising and early investment in technology startups and new ventures. Established 2022. Learn more at publicgoodventures.com.
CONSULTING SERVICES
Stacks Image 2586
ROSSI BIXBY + ASSOCIATES
Specialized technical, business, and communications consulting for biotechnology and biopharma companies advancing solutions for health, food, environment, and security sectors. Established 2020. Visit rossibixby.com to learn about our services.
TECHNOLOGY INCUBATOR
Stacks Image 2596
PLANETARY GENETICS LLC
A technology incubator and innovation engine advancing biotech startups and new ventures. Established 2019. Discover more at planetary-genetics.com.
VENTURE STUDIO
Stacks Image 2464
PUBLIC GOOD VENTURES LLC
Venture studio and management advising company focused on fundraising and early investment in technology startups and new ventures. Established 2021. Learn more at publicgoodventures.com.
TECHNOLOGY INCUBATOR
Stacks Image 2477
PLANETARY GENETICS LLC
A technology incubator and innovation engine advancing biotech startups and new ventures. Established 2019. Discover more at planetary-genetics.com.
CONSULTING SERVICES
Stacks Image 2368
ROSSI BIXBY + ASSOCIATES
Specialized technical, business, and communications consulting for biotechnology and biopharma companies advancing solutions for health, food, environment, and security sectors. Established 2020. Visit rossibixby.com to learn about our services.
STARTUP INVESTMENT OPPORTUNITIES
MIMIGEN TECHNOLOGIES - nanoparticle chemistries for health and biosecurity
Stacks Image 1994
A polymer nanoparticle chemistry platform company pursuing opportunities to develop targeted therapeutics, as well as, novel diagnostics for health and environmental testing. Fundraising 2023.

Visit mimigen.com to learn more.
Stacks Image 2312
A polymer nanoparticle chemistry platform company pursuing opportunities to develop targeted therapeutics, as well as, novel diagnostics for health and environmental testing. Fundraising 2023.

Visit mimigen.com to learn more.
STEALTH MODE NEWCO - therapeutic control platform
Stacks Image 1983
A novel therapeutic technology platform to reduce toxic therapeutic side effects in the treatment of chronic and infectious diseases. Fundraising 2023.

Visit publicgoodventures.com to learn more.
Stacks Image 2323
A novel therapeutic technology platform to reduce toxic therapeutic side effects in the treatment of chronic and infectious diseases. Fundraising 2023.

Visit publicgoodventures.com to learn more.
PROFILES
BIOSKETCH
TODD BIXBY
TODD BIXBY
Mr. Bixby is a biotechnology developer, corporate strategist, life sciences and public health professional with over 20 years experience advancing biotechnologies to promote healthier communities and environments. He has worked to develop and deploy advanced technologies for human health, environmental health, biodefense and national security, sustainable food production, conservation, and consumer products.

He developed groundbreaking FDA cleared products including current tests ensuring safety of U.S. blood supply and launched the APTIMA molecular diagnostics platform. He also participated in the deployment of pioneering advanced diagnostics for low resource settings in Sub-Saharan Africa. He has deep experience with several genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered organism products regulated by FDA, USDA, and EPA. He remains dedicated to developing medicines and supporting interventions aimed at improving global public health and biosecurity.

Mr. Bixby, a San Diego native and graduate of the University of California San Diego, is currently advancing biotechnology startups and new ventures focused on realizing healthier people and a healthier planet.
Mr. Bixby is a biotechnology developer, corporate strategist, life sciences and public health professional with over 20 years experience advancing biotechnologies to promote healthier communities and environments. He has worked to develop and deploy advanced technologies for human health, environmental health, biodefense and national security, sustainable food production, conservation, and consumer products.

He developed groundbreaking FDA cleared products including current tests ensuring safety of U.S. blood supply and launched the APTIMA molecular diagnostics platform. He also participated in the deployment of pioneering advanced diagnostics for low resource settings in Sub-Saharan Africa. He has deep experience with several genetic engineering technologies, as well as first-in-class gene-edited and genetically engineered organism products regulated by FDA, USDA, and EPA. He remains dedicated to developing medicines and supporting interventions aimed at improving global public health and biosecurity.

Mr. Bixby, a San Diego native and graduate of the University of California San Diego, is currently advancing biotechnology startups and new ventures focused on realizing healthier people and a healthier planet.
MULTI-DISCIPLINARY EXPERTISE
Mr. Bixby has multi-disciplinary expertise in corporate strategy, business and corporate development, M&A diligence, technology analysis, new product development, basic and applied research, project management, marketing and communications, strategic alliances, and commercialization.
Mr. Bixby has multi-disciplinary expertise in corporate strategy, business and corporate development, M&A diligence, technology analysis, new product development, basic and applied research, project management, marketing and communications, strategic alliances, and commercialization.
SOCIAL MEDIA
TODD BIXBY
TODD BIXBY
PLANETARY GENETICS
PLANETARY GENETICS
ROSSI BIXBY + ASSOCIATES | BIOTECHNOLOGY & COMMUNICATIONS CONSULTING
ROSSI BIXBY + ASSOCIATES | BIOTECHNOLOGY & COMMUNICATIONS CONSULTING

ADVANCING BIOTECHNOLOGY
FOR HEALTHIER PEOPLE AND
A HEALTHIER PLANET

ADVANCING BIOTECHNOLOGY FOR HEALTHIER PEOPLE AND A HEALTHIER PLANET

Stacks Image 152
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein
We can’t solve problems by using the same kind of thinking we used when we created them.
Albert Einstein

Learn more about biotechnology development experience and affiliations here.

Contact
info@toddbixby.com
Learn more about biotechnology development experience and affiliations here.

Contact
info@toddbixby.com